文献速递神经外周血管CT

利用入院时CT灌注成像的机器学习预测动脉瘤性蛛网膜下腔出血患者的临床结局

Machine Learning Using Presentation CT Perfusion Imaging for Predicting Clinical Outcomes in Patients With Aneurysmal Subarachnoid Hemorrhage.
PubMed 文献 · AJR Am J Roentgenol · 2023-07-19

本研究回顾性分析242例动脉瘤性蛛网膜下腔出血(aSAH)患者入院时的临床与CT灌注数据,构建5种机器学习模型预测迟发性脑缺血(DCI)和3个月功能预后不良(改良Rankin量表评分≥4)。测试集中CatBoost模型预测DCI的AUC为0.949、预测功能预后不良的AUC为0.958,均高于传统临床模型(AUC分别为0.771和0.863),差异有统计学意义(p=.004和p=.04)。

要点

  • 定性CTP分析被识别为预测DCI和3个月功能预后不良影响最大的特征。
  • 测试集中CatBoost预测DCI的敏感度92.3%、特异度85.7%,传统临床模型分别为92.3%和60.0%。
  • 测试集中CatBoost预测3个月功能预后不良的敏感度90.0%、特异度94.7%,传统临床模型分别为100.0%和65.8%。

核心结论

  • 纳入入院临床和CTP数据的机器学习模型在预测DCI和3个月功能预后不良方面优于传统临床模型,可能有助于指导aSAH患者的早期管理。

研究设计与样本

  • 回顾性分析242例aSAH患者(平均年龄60.9±11.8岁;女165例、男77例)的数据,患者作为前瞻性试验的一部分接受了CTP检查,并在初次住院期间接受DCI标准化评估及3个月功能预后不良(改良Rankin量表评分≥4)评估。

诊断标准与关键数值

  • 测试集(n=48)中传统临床模型、KNN、LR、SVM、RF、CatBoost预测DCI的AUC分别为0.771、0.812、0.824、0.908、0.930、0.949。
  • 测试集(n=48)中传统临床模型、KNN、LR、SVM、RF、CatBoost预测3个月功能预后不良的AUC分别为0.863、0.858、0.879、0.908、0.926、0.958。
  • 测试集中CatBoost预测DCI的AUC高于传统临床模型(p=.004),预测3个月功能预后不良的AUC亦高于传统临床模型(p=.04)。
  • 测试集中预测DCI的敏感度和特异度:传统临床模型为92.3%和60.0%,CatBoost为92.3%和85.7%。
  • 测试集中预测3个月功能预后不良的敏感度和特异度:传统临床模型为100.0%和65.8%,CatBoost为90.0%和94.7%。

临床应用与阅片要点

  • 定性CTP分析是预测DCI和3个月功能预后不良影响最大的特征,阅片时可关注CTP定性表现。
  • 基于CatBoost模型创建了网络预测工具。
  • 机器学习模型可能有助于指导aSAH患者的早期管理(原文表述为「may help guide」)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Prediction of outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH) is challenging using current clinical predictors. OBJECTIVE. The purpose of our study was to evaluate the utility of machine learning (ML) models incorporating presentation clinical and CT perfusion imaging (CTP) data in predicting delayed cerebral ischemia (DCI) and poor functional outcome in patients with aSAH. METHODS. This study entailed retrospective analysis of data from 242 patients (mean age, 60.9 ± 11.8 [SD] years; 165 women, 77 men) with aSAH who, as part of a prospective trial, underwent CTP followed by standardized evaluation for DCI during initial hospitalization and poor 3-month functional outcome (i.e., modified Rankin scale score ≥ 4). Patients were randomly divided into training (n = 194) and test (n = 48) sets. Five ML models (k-nearest neighbor [KNN], logistic regression [LR], support vector machine [SVM], random forest [RF], and category boosting [CatBoost]) were developed for predicting outcomes using presentation clinical and CTP data. The least absolute shrinkage and selection operator method was used for feature selection. Ten-fold cross-validation was performed in the training set. Traditional clinical models were developed using stepwise LR analysis of clinical, but not CTP, data. RESULTS. Qualitative CTP analysis was identified as the most impactful feature for both outcomes. In the test set, the traditional clinical model, KNN, LR, SVM, RF, and CatBoost showed AUC for predicting DCI of 0.771, 0.812, 0.824, 0.908, 0.930, and 0.949, respectively, and AUC for predicting poor 3-month functional outcome of 0.863, 0.858, 0.879, 0.908, 0.926, and 0.958. CatBoost was selected as the optimal model. In the test set, AUC was higher for CatBoost than for the traditional clinical model for predicting DCI (p = .004) and poor 3-month functional outcome (p = .04). In the test set, sensitivity and specificity for predicting DCI were 92.3% and 60.0% for the traditional clinical model versus 92.3% and 85.7% for CatBoost, and sensitivity and specificity for predicting poor 3-month functional outcome were 100.0% and 65.8% for the traditional clinical model versus 90.0% and 94.7% for CatBoost. A web-based prediction tool based on CatBoost was created. CONCLUSION. ML models incorporating presentation clinical and CTP data outperformed traditional clinical models in predicting DCI and poor 3-month functional outcome. CLINICAL IMPACT. ML models may help guide early management of patients with aSAH.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Yin P, Wang J, Zhang C, et al. Machine Learning Using Presentation CT Perfusion Imaging for Predicting Clinical Outcomes in Patients With Aneurysmal Subarachnoid Hemorrhage. AJR Am J Roentgenol. 2023. PMID: 37466187. doi:10.2214/AJR.23.29579

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。